Drug intelligence / Profile preview

prothrombin complex concentrate (Shanghai RAAS)

Development stage
Unknown
Lead developer
Shanghai Raas
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Prothrombin complex concentrate (PCC) is a plasma-derived biologic containing the vitamin K-dependent coagulation factors II (prothrombin), VII, IX, and X. Developed by Shanghai RAAS Blood Products and branded as PROTHORAAS, it is used for the rapid reversal of hemorrhage induced by coumarin-type anticoagulants, the treatment of bleeding in Hemophilia A patients with Factor VIII inhibitors, and the pre-surgical management of prolonged prothrombin time. By replenishing these essential clotting factors, PCC restores the coagulation cascade's ability to generate thrombin and achieve hemostasis. It is administered intravenously as a reconstituted freeze-dried powder and is approved for marketing in China.

Brand names
PROTHORAASProthrombin RAAS
Other names
Prothrombin ComplexPCChuman prothrombin complex concentrate
02

Targets

F2 (Thrombin)F7 (Coagulation Factor VII)F9 (Coagulation Factor IX)F10 (Factor Xa)

Beyond the preview

Go deeper on prothrombin complex concentrate (Shanghai RAAS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prothrombin complex concentrate (Shanghai RAAS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call